Hydrea 500 mg is a prescription cytotoxic antimetabolite containing hydroxyurea. It is used in:
Chronic myeloid leukemia (CML) to reduce leukocyte counts and control disease
Head and neck cancers and other solid tumors as part of chemotherapy regimens
Sickle cell disease to reduce vaso-occlusive crises and red cell sickling
Hydroxyurea works by inhibiting ribonucleotide reductase, suppressing DNA synthesis in rapidly dividing cells. It may also promote fetal hemoglobin production, reducing sickling in sickle cell patients.
Select options
This product has multiple variants. The options may be chosen on the product page
Hydroxychloroquine 200 mg is a prescription medication trusted for decades to manage malaria and autoimmune conditions. Originally developed as an antimalarial, it prevents and treats malaria by interfering with the parasite’s ability to grow inside red blood cells. Today, its uses extend beyond malaria—hydroxychloroquine is also prescribed for rheumatoid arthritis and lupus erythematosus, where it helps reduce inflammation, joint pain, and skin rashes by regulating overactive immune responses.
Known for its flexible dosing, hydroxychloroquine is taken daily in autoimmune conditions or weekly when used as malaria prevention. Its long history of effectiveness, safety profile, and wide applications make it a cornerstone therapy in both tropical medicine and rheumatology.
Select options
This product has multiple variants. The options may be chosen on the product page
IMAT 100 mg is an oral tablet formulation of imatinib, a selective tyrosine kinase inhibitor (TKI). It is indicated for adult patients with chronic myeloid leukemia (CML), Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), and c-KIT+ gastrointestinal stromal tumors (GIST). Imatinib targets BCR-ABL, c-KIT, and PDGFR tyrosine kinases, effectively blocking malignant cell growth and disease progression.
Select options
This product has multiple variants. The options may be chosen on the product page
IMAT 400 mg is a higher-strength oral tablet formulation of imatinib, a selective tyrosine kinase inhibitor (TKI). It’s indicated for patients with advanced or resistant chronic myeloid leukemia (CML), Philadelphia chromosome–positive acute lymphoblastic leukemia (Ph+ ALL), and c-KIT+ gastrointestinal stromal tumors (GIST). By inhibiting BCR‑ABL, c‑KIT, and PDGFR tyrosine kinases, imatinib halts cancer cell growth and improves disease outcomes.
Select options
This product has multiple variants. The options may be chosen on the product page
Imatib 400 mg is a high-dose oral formulation of imatinib mesylate—a selective tyrosine kinase inhibitor that targets BCR‑ABL, c‑KIT, and PDGFR. It is indicated for adult patients with chronic myeloid leukemia (CML), Philadelphia chromosome‑positive acute lymphoblastic leukemia (Ph+ ALL), and c‑KIT positive gastrointestinal stromal tumors (GIST), especially in advanced or resistant disease settings. By inhibiting these kinases, Imatib disrupts cancer cell signaling to help achieve disease control.
Select options
This product has multiple variants. The options may be chosen on the product page
Imiquad Sachet contains Imiquimod, a topical immune response modifier designed to treat various skin conditions like genital warts, actinic keratosis, and superficial basal cell carcinoma. This single-use sachet ensures clean and accurate dosing with every application.
Imiquad works by stimulating the body’s natural defenses to fight abnormal skin growths and viral infections at the local application site.
Select options
This product has multiple variants. The options may be chosen on the product page
Primary superficial basal cell carcinoma (when surgery isn’t suitable)
External genital and perianal warts (from HPV) in individuals 12 years and older
It works by stimulating the body’s immune system to produce cytokines (e.g. interferon‑α) that help clear abnormal or infected cells. The cream is applied to the affected skin and left for several hours to trigger a local response.
Select options
This product has multiple variants. The options may be chosen on the product page
Imutrex 10 mg delivers a controlled dose of methotrexate for managing autoimmune diseases such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. This tablet offers flexibility and consistency for weekly dosing, aiding in inflammation reduction and disease progression control.
Select options
This product has multiple variants. The options may be chosen on the product page
Imutrex 2.5 mg contains a low-dose of methotrexate, a folate antagonist used to treat autoimmune diseases such as rheumatoid arthritis, severe psoriasis, and select cancers. This low-dose formulation allows for accurate weekly dosing to manage inflammation and cell proliferation—with minimized side effects and convenient handling.
Select options
This product has multiple variants. The options may be chosen on the product page
Imutrex 7.5 mg delivers a controlled dose of methotrexate, widely used for treating autoimmune conditions such as rheumatoid arthritis, psoriasis, and psoriatic arthritis. This tablet format allows flexible weekly dosing, supporting inflammation management and slowing progression with greater ease and consistency.
Select options
This product has multiple variants. The options may be chosen on the product page
Inhalex Respules contain Ambroxol 15 mg per 2 ml respule, formulated for inhalation via nebulizer. It acts as a mucolytic agent, thinning and loosening thick mucus in the airways, making it easier to cough out and improving breathing in conditions characterized by excessive or sticky sputum.
Select options
This product has multiple variants. The options may be chosen on the product page
End of content
End of content
Join our newsletter and get 50% off your first order
Subscribe to our newsletter and get the latest trending products and offers updates.
Wait! before you leave…
We have something special for you
Use above code to get 20% off for your first order when checkout. Don't miss it.